Martin Smetana

Prepare for Meeting →

Chief Financial Officer

Neulogy Ventures

Check size: €200K-€3M investments, as published by Neulogy Ventures.

Investment Thesis

Martin Smetana is listed in a Chief Financial Officer capacity at Neulogy Ventures. The firm does not publish a person-specific investment thesis for this role; firm strategy is included only as shared context.

What Excites Them

Moonshot ideas that push technology, climate or health forward, led by humble and competent founders with audacious long-term ambition.

What They Pass On

Companies without meaningful innovation, Slovak operating relevance or a fit with the firm's technology, climate and health mandate are less aligned.

How to Pitch

Show the technical frontier, founder insight, evidence, Slovak or CEE connection, positive impact and milestones that €200K-€3M can unlock.

Notable Writing

No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.

Podcast Appearances

No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.

Key Quotes

Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.

Background

Martin Smetana is a current Chief Financial Officer at Neulogy Ventures, according to the firm's official roster. No education, prior employment or personal deal claims are inferred where the firm does not publish them.

Share
Requests are processed by our agent pipeline nightlyIs this you? Request removal